Amgen, Inc. (AMGN)

344.76 -2.31 (-0.67%) USD  |  NASDAQ  |  Jan 23, 16:00
344.57 -0.19 (-0.06%) After-Hours: 16:32
More

Amgen Land and Improvements (Annual)

Land and Improvements (Annual) Chart

View Land and Improvements (Annual) for AMGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Land and Improvements (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Land and Improvements Definition

View Land and Improvements Definition
Start Trial

Land and Improvements is a long term asset and will depreciate over time. The depreciation will show up as a debit on the income statement.

Read full definition.

Land and Improvements (Annual) Range, Past 5 Years

View Land and Improvements (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Land and Improvements (Annual) Benchmarks

View Land and Improvements (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Johnson & Johnson --
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade